Fusion Pharmaceuticals Inc. Gains 21.76%

Tue, Feb 14, 2023 at 07:16 PM
Fusion Pharmaceuticals Inc. Gains 21.76%

Fusion Pharmaceuticals Inc. (FUSN:NASDAQ) jumped higher at $4.42, representing a gain of 21.8%. On Tue, Feb 14, 2023, FUSN:NASDAQ touched a New 2-Week High of $4.42. The stock appeared on our News Catalysts scanner on Tue, Feb 14, 2023 at 10:11 AM in the 'BIOTECH' category. From Tue, Jan 31, 2023, the stock recorded 80.00% Up Days and 36.36% Green Days

About Fusion Pharmaceuticals Inc. (FUSN:NASDAQ)

Fusion Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing alpha therapeutics for curing cancer.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.